논문KCI 등재
Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
참고문헌 (17)
- Cederholm T, "ESPEN guidelines on definitions and terminology of clinical nutrition", Clin Nutr, 36, pp.49~64 (2017)
- DiMartini A, "Muscle mass predicts outcomes following liver transplantation", Liver Transpl, 19, pp.1172~1180 (2013)
- Tantai X, "Effect of sarcopenia on survival in patients with cirrhosis : a meta-analysis", J Hepatol, 76, pp.588~599 (2022)
- Ji Won Han, "Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis", Clinical and Molecular Hepatology, 28(2), pp.219~231 (2022), 대한간학회[DOI]
- Kanghyug Choi, "The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma", Clinical and Molecular Hepatology, 26(4), pp.492~505 (2020), 대한간학회[DOI]
- Montano-Loza AJ, "Muscle wasting is associated with mortality in patients with cirrhosis", Clin Gastroenterol Hepatol, 10, pp.166~173 (2012)
- Dae Hoe Gu, "Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis", Clinical and Molecular Hepatology, 24(3), pp.319~330 (2018), 대한간학회
- Lai JC, "Malnutrition, frailty, and sarcopenia in patients with cirrhosis : 2021 practice guidance by the American Association for the Study of Liver Diseases", Hepatology, 74, pp.1611~1644 (2021)
- European Association for the Study of the Liver(EASL), "EASL clinical practice guidelines on nutrition in chronic liver disease", J Hepatol, 70, pp.172~193 (2019)
- Bischoff SC, "ESPEN practical guideline : clinical nutrition in liver disease", Clin Nutr, 39, pp.3533~3562 (2020)
- Tae Hyung Kim, "Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis", Clinical and Molecular Hepatology, 28(4), pp.876~889 (2022), 대한간학회
- Ebadi M, "Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis", J Hepatol, 69, pp.608~616 (2018)
- Sinclair M, "Review article : sarcopenia in cirrhosis-aetiology, implications and potential therapeutic interventions", Aliment Pharmacol Ther, 43, pp.765~777 (2016)
- Dasarathy J, "Sarcopenia in alcoholic liver disease : clinical and molecular advances", Alcohol Clin Exp Res, 41, pp.1419~1431 (2017)
- Chapman B, "Malnutrition in cirrhosis : more food for thought", World J Hepatol, 12, pp.883~896 (2020)
- Bellar A, "Exercise and physical activity in cirrhosis: opportunities or perils", J Appl Physiol(1985), 128, pp.1547~1567 (2020)
- Ebadi M, "Myosteatosis in cirrhosis : a review of diagnosis, pathophysiological mechanisms and potential interventions", Cells, 11, pp.1216~ (2022)
관련 논문AI추천
Reply to Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”Hyung Joon Yim, Tae Hyung Kim, Young Kul Jung대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호Correspondence on Letter regarding “Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study”Hideki Fujii, Michihiro Iwaki, Yoshihiro Kamada대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제2호Correspondence to editorial on “Risk stratification by noninvasive tests in patients with metabolic dysfunc tion-associated steatotic liver disease”Hye Won Lee, Seung Up Kim대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Prognostic implications of trunk muscle mass in liver cirrhosis김원, Jimin Han대한간학회 · Clinical and Molecular Hepatology2018 · 제24권 제3호Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction- associated steatotic liver disease and cirrhosis”Weixiong Zhu, Wence Zhou, Xuefan Zeng, Yusheng Cheng, Zengxi Yang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제3호Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction- associated steatotic liver disease and cirrhosis”Ailei Xu, Wei Wang, Yating Xie대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호
이 간행물의 다른 논문 (46건)
Subclinical versus advanced forms of alcohol-related liver disease: Need for early detectionLuma Melo, David Martí-Aguado, Ramón Bataller, Concepción Gómez-Medinapp. 1-15PrefaceYoon Jun Kimpp. 2-2PrefaceSeung Up Kimpp. 3-3Non-alcoholic fatty liver disease: Definition and subtypesSeul Ki Han, 김문영, 백순구pp. 5-16Management of refractory ascitesFlorence Wongpp. 16-32
